Combination therapy improves anthrax survival

BALTIMORE March 10, 2003 Treating anthrax patients with a combination of antibiotics and antibodies could greatly improve their likelihood of survival, say researchers today at the American Society for Microbiology's Biodefense Research Meeting.

"Currently there is no effective treatment for inhalation anthrax beyond administration of antibiotics shortly after exposure," says Vladimir Karginov of Advanced Biosystems, Inc. in Manassas, Virginia, a lead researcher in the study. "Time delay reduces the effectiveness of antibiotic treatment. There is need for new, safe and effective treatments to supplement traditional antibiotic therapy."

Antibiotic therapy for inhalation anthrax is generally only effective if it is started within days of exposure, before symptoms appear. By the time symptoms do appear antibiotics alone will not work because while they do kill the bacteria, anthrax toxin has already accumulated in the body to dangerous levels and the chances of dying are extremely high.

Karginov and his colleagues have developed a treatment strategy that addresses this problem. In addition to antibiotics to kill the infection, patients can also be given antibodies that programmed to attack a part of the toxin called the protective antigen and prevent it from doing damage.

"In animals infected with a dose of anthrax spores sufficient to cause 80 percent mortality, antibiotic treatment with ciprofloxacin alone only cures 50 percent of infected animals," says Karginov. "In contrast, administration of rabbit antibodies either against heat inactivated anthrax bacteria or against protective antigen in combination with ciprofloxacin produced 100 percent survival."


Contact: Jim Sliwa
American Society for Microbiology

Page: 1

Related biology news :

1. Combination of gene therapy and gene silencing prevents neurodegenerative disease
2. Combination therapy dramatically improves function after spinal cord injury in rats
3. Combination therapy drives cancer into remission
4. Combination drug therapy drastically reduces multiple coronary heart disease risk factors
5. Drug Combination May Prove Effective To Prevent Recurrence Of Hepatitis C After Transplantation
6. Combination Therapy For Brain Tumors Holds Promise For Longer Survival After Surgery
7. New Heart-Attack Indicator Dramatically Improves Diagnostic Accuracy Of ER Doctors: TnT/Echocardiogram Combination Could Reduce Needless Admissions
8. Dangerous Chemical Combination Presents Possible Scenario For Gulf War Illnesses
9. Targeted therapy knocks out pediatric brain cancer in mice
10. New anti-inflammatory strategy for cancer therapy identified by UCSD researchers
11. Columbia research to examine gene influence on severity of peridontal disease, therapy response

Post Your Comments:

(Date:8/21/2020)... ... 19, 2020 , ... “How can we help?”, asks Hans ... Bioscience for more than twenty years. Together with Douglas Granger, Ph.D., founder of ... Foundations of Interdisciplinary Saliva Research and Applications ," and Steven Granger, Ph.D., Chief ...
(Date:8/21/2020)... ... August 20, 2020 , ... ... Movahhed , a Clinical Operations executive with expertise in clinical trial planning and ... firm as an Expert Consultant. Throughout his career, Mr. Movahhed has helped design ...
(Date:8/12/2020)... ... August 12, 2020 , ... Mosio recently ... ideal for public health agencies of all sizes. With a focus on tracking ... individuals find appropriate health care, Mosio helps public health departments automate communications and ...
Breaking Biology News(10 mins):
(Date:8/31/2020)... ... August 29, 2020 , ... DuPont ... capability in Wuxi, China. The new plant operation will provide the local animal ... technology. , “This facility will improve the flexibility of our offerings to ...
(Date:8/12/2020)... ... August 11, 2020 , ... ... cold chain validation engineering firm, is making available for free its new ... to incorporate concurrent transport simulation testing into today’s biologics licensing application (BLA). ...
(Date:8/3/2020)... , ... August 03, 2020 , ... Introducing Ardent Animal ... transformative growth, , Known as MediVet Biologics since its formation ... The new Ardent Animal Health will build on its base of innovative ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... combine up to three different materials for use with CRM, neurostimulation, vascular, and ... three materials to meet specific design requirements, performance, and cost criteria; especially where ...
Breaking Biology Technology:
Cached News: